TherapeuticsMD | TXMD - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
AbbVie USD 6.57B 2.82B 2026-06
Alterity Therapeutics Limited AUD 15.77M 9.56M 2023-06
Cipla INR 10.18B 2.22B 2026-03
Clal Biotechnology ILS 5.73M 1.71M 2023-12
Compugen USD 12.43M 78.16M 2026-03
CSL USD 2.16B 633M 2025-06
Grifols EUR 979.78M 334.84M 2024-12
Novo Nordisk DKK 21.13B 17.81B 2026-03
Pfizer USD 976M 727M 2026-06
TherapeuticsMD 523K 89K 2024-06